This proposal tests the hypothesis that genetic alterations in oral cavity epithelium lead to dysplasia and ultimately to invasive squamous cell carcinoma (SCC). It is further hypothesized that gene amplification and mutation are crucial alterations in the development of these tumors, and that these alterations, and their expression, can be detected using fluorescence in situ hybridization (FISH), in situ hybridization (ISH), and immunohistochemistry (IHC). Three candidate genes which are frequently amplified (prad1 and ems1) or mutated (p53) in invasive oral cavity SCC will be analyzed to identify the frequency of these alterations in preinvasive oral cavity lesions. The training period to carry out the proposed research has been divided into Phase I and Phase II. Phase I of the proposal (years 1 and 2) will aim to identify, in preinvasive oral cavity lesions, the frequency of: a) amplication of prad1 and ems1 using FISH; b) increased transcription of prad1 and ems1 using ISH; and c) protein overexpression of prad1, ems1 and mutant p53 using IHC. After this has been accomplished, phase II, which evaluates the importance of these alterations in oral cavity tumorigenesis, will begin. Phase II of the proposal (years 3-5) will involve the analysis of the in vitro and in vivo function of these altered genes through transfection into normal human buccal keratinocytes. Transfection will involve one gene, combinations of two genes, or all three genes. Transfected cells will be evaluated for evidence of transformation using techniques known to correlate with carcinogenic potential: increased cytoskeletal protein expression, increased expression of ornithine decarboxylase, and changes in cell growth characteristics (morphology, need for growth factors, immortalization, and anchorage independent growth in semi-solid media). Those cells that grow in semi-solid media, or, alternatively, cells which have two or more other signs of transformation, will be injected into nude mice, and the mice observed for signs of tumor formation. The data obtained from this research will lead to a better understanding of the important genetic events in oral cavity tumorigenesis. The training from this project should provide the candidate with an excellent foundation for an independent career in biomedical research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Physician Scientist Award (K11)
Project #
5K11DE000380-04
Application #
2700983
Study Section
Cancer Institutional Fellowship Review Committee (CT)
Project Start
1995-05-01
Project End
2000-04-30
Budget Start
1998-05-01
Budget End
1999-04-30
Support Year
4
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Fox Chase Cancer Center
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Mankani, Mahesh H; Kuznetsov, Sergei A; Marshall, Grayson W et al. (2008) Creation of new bone by the percutaneous injection of human bone marrow stromal cell and HA/TCP suspensions. Tissue Eng Part A 14:1949-58
Tsutsui, T W; Riminucci, M; Holmbeck, Kenn et al. (2008) Development of craniofacial structures in transgenic mice with constitutively active PTH/PTHrP receptor. Bone 42:321-31
Bianco, Paolo; Robey, Pamela Gehron; Simmons, Paul J (2008) Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2:313-9
Robey, Pamela Gehron; Bianco, Paolo (2006) The use of adult stem cells in rebuilding the human face. J Am Dent Assoc 137:961-72
Kuznetsov, Sergei A; Riminucci, Mara; Ziran, Navid et al. (2004) The interplay of osteogenesis and hematopoiesis: expression of a constitutively active PTH/PTHrP receptor in osteogenic cells perturbs the establishment of hematopoiesis in bone and of skeletal stem cells in the bone marrow. J Cell Biol 167:1113-22
Sauter, Edward R; Takemoto, Richelle; Litwin, Samuel et al. (2002) p53 alone or in combination with antisense cyclin D1 induces apoptosis and reduces tumor size in human melanoma. Cancer Gene Ther 9:807-12
Sauter, Edward R; Yeo, Un-Cheol; von Stemm, Andrea et al. (2002) Cyclin D1 is a candidate oncogene in cutaneous melanoma. Cancer Res 62:3200-6
St John, L S; Sauter, E R; Herlyn, M et al. (2000) Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53. Cancer Gene Ther 7:749-56
Sauter, E R; Herlyn, M; Liu, S C et al. (2000) Prolonged response to antisense cyclin D1 in a human squamous cancer xenograft model. Clin Cancer Res 6:654-60
Sauter, E R; Nesbit, M; Watson, J C et al. (1999) Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. Clin Cancer Res 5:775-82

Showing the most recent 10 out of 11 publications